Navigation Links
MU researchers find clue to cataract formation
Date:4/17/2008

peptides increase, the eyes lens starts to develop cataracts. There are a variety of causes that lead to the decrease of chaperone activity, and the presence of these small peptides accelerates the process, Sharma said.

Its a very sad situation, because cataracts can have a huge impact on the quality of a persons life, Sharma said. People lose the ability to appreciate visual art and have to learn a new set of skills to navigate. This study will bring us another step closer to understanding how cataracts form in the eye and how best to treat this debilitating disease.

Approximately 50 percent of cataract formation in older individuals is age related, but other risk factors include genetics, smoking, exposure to UV light and diabetes. According to the National Eye Institute, symptoms of early cataracts may be improved with new eyeglasses, brighter lighting, anti-glare sunglasses or magnifying lenses. If these measures do not help, surgery is the only effective treatment. Surgery involves removing the cloudy lens and replacing it with an artificial lens.


'/>"/>

Contact: Christian Basi
BasiC@missouri.edu
573-882-4430
University of Missouri-Columbia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers evaluating food allergy treatment
2. U of M researchers identify process that may help treat Parkinsons, spinal cord injuries
3. OHSU Cancer Institute researchers discover key gene involvement in cancer development
4. Combining liver cancer treatments doubles survival rates, UVA researchers find
5. Leading HIV researchers to collaborate on vaccine development
6. Georgetown researchers find stem cell marker controls 2 key cancer pathways
7. Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find
8. OHSU Cancer Institute researchers find connection between protein, prognosis in breast cancer
9. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
10. Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer
11. Researchers find disparities in depression among older Hispanics in US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Glidewell Laboratories, industry-leading provider of ... the new issue of Chairside® magazine, its restorative-dentistry-focused ... The digital edition of the latest issue, Volume ... of the dental laboratory’s magazine, can be viewed ... by visiting http://www.chairsidemagazine.com . , In the ...
(Date:6/2/2015)... 2015 Residents of Monarch Landing in ... take a fitness class, do yoga, play volleyball, or ... preparation for the Alzheimer’s Association’s Walk to End Alzheimer’s ... take part in a challenge to exercise for 60 ... management company. , While the walk will raise awareness ...
(Date:6/2/2015)... June 02, 2015 Consumer Reports, ... organization, today announced its commitment to help wipe ... the use of antibiotics sicken about 2.25 million ... the Centers for Disease Control and Prevention. , ... and CEO Marta Tellado participating in the White ...
(Date:6/2/2015)... FDA approved Orlistat for weight loss ... satisfactory doctor consultation. The less potent, over-the-counter version of Orlistat, ... has the longest track record as an FDA approved weight ... down fats in foods, Orlistat treatment prevents the body from ... be excreted through feces. , The most common ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Date: Thursday, ... Philadelphia City Council Chamber, 494 N. Broad Street, 4th ... the Hepatitis B Foundation will visit Philadelphia ... testing for hepatitis B and hepatitis C in Philadelphia’s ... education campaign they have created, Hep B United Philadelphia ...
Breaking Medicine News(10 mins):Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 2Health News:Glidewell Laboratories Releases New Issue of Restorative Dentistry Magazine Chairside in Print and Online 3Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 2Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 4Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2
... of Hong Kong’s air quality has resulted in increasing number ... ,The deterioration of Hong Kong’s air quality has resulted ... problems. , , ,Researchers at Hong Kong ... sulphur dioxide, nitrogen dioxide and ozone of about three percent ...
... The U.S. Food and Drug Administration (FDA) have approved a ... meats. This approval was given last month.// , ... Listeria. The approved spray is a combination of viruses that ... these foods before packaging and distribution. ,This virus ...
... the latest issue of the New England Journal of Medicine ... However more research is needed to ascertain// these findings. ... given to survivors of heart attacks and found that these ... whether stem cells could repair the main pumping chamber of ...
... body wrap or deep relaxation with Indian ayurvedic therapeutic oils ... ago. ,But they are rapidly becoming a ... seek a pampered lifestyle in the country's ever more numerous ... a few very feminine hours in one of Warsaw's spas," ...
... reported having updated the warning label on the Ortho ... of blood clots from it.// ,The drug manufacturer ... faced two times the risk of clots in the ... pills. ,Another study commissioned by Johnson and Johnson, ...
... to health experts, 80% of people suffering from severe ... not even aware of it.// ,Chronic Bronchitis and ... Long-term damage to lung tissue by smoking can lead ... COPD. ,Professor Robert West, director of tobacco ...
Cached Medicine News:Health News:Luxury Spas Ride Boom in Wellness Industry in Poland 2Health News:Contraceptive Patch Carries Risk of Blood clots 2Health News:80% of lung disease remains ‘undiagnosed’. 2
(Date:6/2/2015)... , June 2, 2015 ... Society of Clinical Oncology    PharmaMar comunica ... SAR3007, resi noti dal dipartimento Ricerca e sviluppo ... miglioramento della sopravvivenza libera da progressione (PFS) dopo il ... con dacarbazina in pazienti con liposarcoma (LPS) o leiomiosarcoma ...
(Date:6/1/2015)... OAKS, Calif. , June 2, 2015 /PRNewswire/ ... a collaboration with Roche on a Phase 1b ... talimogene laherparepvec, Amgen,s investigational oncolytic immunotherapy, in combination ... as MPDL3280A), in patients with triple-negative breast cancer ... Talimogene laherparepvec is an investigational oncolytic immunotherapy designed ...
(Date:6/1/2015)... , June 1, 2015 ... ) has announced the addition of the ... Displays Market" report to their offering. ... report provides an in-depth analysis of the ... forecast, market shares, market dynamics, and trends ...
Breaking Medicine Technology:PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 2Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 3Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 4Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 5Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 7Analysis of the US Medical Image Displays Market 2015-2017 2
... DIEGO, March 14, 2012 OncoSec Medical ... OncoSec Medical System (OMS) ElectroOncology therapies to treat ... Cancer Institute in Santa Monica, CA, and Lakeland ... initiated as enrolling sites, and investigators are screening ...
... YORK, March 14, 2012 Reportlinker.com ... report is available in its catalogue: ... Market Outlook in BRICS (Brazil, Russia, ... http://www.reportlinker.com/p0796126/Respiratory-Devices-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Respiratory_Devices ...
Cached Medicine Technology:OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 16Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 17Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 18Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 19
... The Mini-Sub cell GT system, ... and mini-gel caster, is used for ... acids in mini format agarose gels. ... 7 x 7 cm UV-transparent gel ...
... The wide Mini-Sub cell GT system, with ... caster, is used for submerged horizontal gel ... agarose gels. The system includes an electrophoresis ... tray, casting gates, mini-gel caster, and two ...
... Most gels can be dried by positioning them ... dryer, covering them with wet semi-permeable cellophane and ... cellophane flat. Tut's Tombs also produce great fluorographs. ... larger than the gel to be dried. Note ...
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
Medicine Products: